Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Histogen Granted European Patent Titled ‘EXTRACELLULAR MATRIX COMPOSITIONS’

Legal
News

Histogen Granted European Patent Titled ‘EXTRACELLULAR MATRIX COMPOSITIONS’

https://register.epo.org/application?number=EP09706122

byBenzinga Newsdesk

August 19, 2022

1 minute read

https://register.epo.org/application?number=EP09706122

Goldman Sachs Maintains Buy on Global E Online, Raises Price Target to $31

By Benzinga Newsdesk

July 14, 11:27 AM

Goldman Sachs analyst Will Nance maintains Global E Online (NASDAQ:GLBE) with a Buy and raises the price target from $28 to $31.

GLBE

Why Titan Machinery Shares Are Rocketing Today?

By Lekha Gupta

August 31, 10:36 AM

Titan Machinery Inc (NASDAQ: TITN) shares are shooting higher by around 12% after reporting

TITN

These Analysts Revise Their Forecasts On Oxford Industries Following Q4 Results

By Avi Kapoor

April 1, 2:51 PM

Oxford Industries, Inc. (NYSE: OXM) reported downbeat financial results for its fourth quarter and issued weak guidance for the first quarter on Thursday.

OXM

B. Riley Securities Maintains Buy on DZS, Lowers Price Target to $23

By Benzinga Newsdesk

February 17, 10:15 AM

B. Riley Securities analyst Dave Kang maintains DZS (NASDAQ:DZSI) with a Buy and lowers the price target from $28 to $23.

DZSI

Histogen Granted European Patent Titled ‘EXTRACELLULAR MATRIX COMPOSITIONS’

Related Posts

Goldman Sachs Maintains Buy on Global E Online, Raises Price Target to $31

Why Titan Machinery Shares Are Rocketing Today?

These Analysts Revise Their Forecasts On Oxford Industries Following Q4 Results

B. Riley Securities Maintains Buy on DZS, Lowers Price Target to $23